Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. 

Biotechnology

Systems Oncology

Spyro Mousses

Katy Marhenke

Robert G. Petit II

Lizette Castano

Marvin O’Ketch

Andrew Matricaria

David Lee

Daniel D. Von Hoff

The board of directors at Systems Oncology have a history in various aspects of the medical field, including research and development positions at different companies. They also have experience as consultants and scholars at different institutions. The board members all have a background in Chemistry and Biology, giving them the scientific knowledge needed to make informed decisions about the company's direction.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Systems Oncology

Leadership Team

CEO and Executive Team